Contact Information 
Capitol Office 
41-B East Wing, Main Captitol 
P.O. Box 202117
Harrisburg PA 17120-2117
Phone: (717) 787-1117
Fax: (717) 705-1889
Open 9 a.m. to 4:30 p.m.

District Offices
105 Lieutenant Michael Cleary Drive
Dallas, PA 18612
(570) 675-6000
Fax: (570) 255-0133
(800) 278-3930
Open 8:30 a.m. to 4:30 p.m.

133 West Tioga St., Suite 4
Tunkhannock, PA 18657
(570) 836-4777
Fax: (570) 836-4772
Open 8:30 a.m. to 4:30 p.m.

email: kboback@pahousegop.com

Boback Introduces Resolution to Protect Men’s Health
12/20/2011
HARRISBURG – Rep. Karen Boback (R-Columbia/Luzerne/Wyoming) announced today that she is introducing a resolution aimed at protecting men’s health by requesting that Congress apply the American Cancer Society’s prostate cancer screening guidelines in its health care decisions.

“I introduced this resolution because the United States Preventive Services Task Force is again tinkering with the health and lives of Americans with its penny-pinching health care recommendations,” said Boback. “Early screening and detection of cancer improves treatment outcomes and saves lives. With so many men being diagnosed with prostate cancer, why would we even consider reducing screening?”

Boback introduced the resolution in reaction to draft recommendations by the United States Preventive Services Task Force (USPSTF) that propose reducing the use of the Prostate-Specific Antigen (PSA) test for early prostate cancer screening, citing false-positive results and subsequent unnecessary cancer treatment. The USPSTF reported similar grounds when, in 2009, it recommended decreasing breast cancer screening for women.

“I fought against the task force recommendations for breast cancer screening, and I will fight against these draft recommendations for prostate screening because the task force is wrong,” said Boback. “Nobody wants a false-positive cancer test result, but a false positive is far better than an undetected positive. These screenings have been proven to save lives, and I encourage men to speak with their health care providers to assess their risks and screening needs.”

Prostate cancer is the most commonly diagnosed non-skin cancer in U.S. men, and 1 in 36 men in the U.S. will die of prostate cancer. Risk factors for prostate cancer include age, race and family history.

Boback thanked Dr. Ira C. Grossman of the Urology Associates of Kingston for his letter to the editor to the Citizens Voice in November stating his concerns with the USPSTF’s latest draft. In his letter, Grossman pointed out that there was not a urologist or an oncologist on the USPSTF panel that drafted the recommendations.

The American Urological Association strongly opposes the USPSTF recommendations, and it, along with the Prostate Cancer Foundation, supports the continued use of PSA screening.

The American Cancer Society’s guidelines for prostate cancer specify that the discussion between a man and his physician regarding prostate cancer should take place between ages 40 and 50, based on the level of risk and family history of prostate cancer.

House Resolution 523 is awaiting consideration by the House Health Committee.

More information about Boback and her legislative priorities is available at RepBoback.com or Facebook.com/RepBoback.

State Representative Karen Boback
117th District, Pennsylvania House of Representatives
Contact: Nicole Wamsley 
nwamsley@pahousegop.com 
717.783.8063
Share |